Carbokem Novo 150mg Injection
Marketer
Alkem Laboratories Ltd
Salt Composition
Carboplatin (150mg)
Overview Carbokem Novo 150mg Injection
NovoCarbokem 150mg injection treats ovarian and small-cell lung cancers by inhibiting cancerous cell proliferation. Administered intravenously under medical supervision, dosage and frequency are determined by your physician based on your condition and may vary. Adhere strictly to the prescribed regimen; improper use or overdose can lead to severe adverse reactions. Therapeutic effects may take weeks or months to manifest; discontinue only under physician instruction. Common side effects include nausea, vomiting, tiredness, and elevated liver enzymes. This medication can lower blood cell counts, increasing infection and bleeding risk. Report fever, sore throat, chills, unusual bleeding/bruising, or dark urine immediately. Regular blood tests monitoring blood cell counts, heart, liver function, and uric acid are essential. Report any allergic reactions like rash, itching, or respiratory distress. Inform your healthcare provider of all other medications you are taking due to potential interactions. Pregnancy and breastfeeding are contraindications. Effective contraception for both partners is crucial throughout treatment to prevent conception.
Uses of Carbokem Novo 150mg Injection
Cancers of the ovary and small-cell lung
Major Benefits of Carbokem Novo 150mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Carbokem Novo 150mg Injection:
- Nausea
- Vomiting
- Anemia (low number of red blood cells)
- Fatigue
- Low blood platelets
- Increased liver enzymes
- Decreased white blood cell count (neutrophils)
- Stomatitis (Inflammation of the mouth)
- Peripheral neuropathy (tingling and numbness of feet and hand)
- Diarrhea
How to use Carbokem Novo 150mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
How Carbokem Novo 150mg Injection works:
Carbokem Novo 150mg injection is a cancer treatment that disrupts the genetic structure (DNA and RNA) of malignant cells, thereby halting their proliferation and expansion.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Carbokem Novo 150mg Injection may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering Carbokem Novo 150mg Injection during pregnancy poses a confirmed risk to fetal development and is therefore contraindicated. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known dangers. Physician consultation is essential.
Breast feedingUNSAFE
Administering Carbokem Novo 150mg Injection while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
Carbokem Novo 150mg Injection can cause drowsiness, blurred vision, and dizziness. Driving should be avoided if these effects are experienced.
KidneyCAUTION
Patients with impaired kidney function should use Carbokem Novo 150mg Injection cautiously, potentially requiring dosage modification. Physician consultation is essential. Carbokem Novo 150mg Injection is contraindicated in individuals with severe kidney disease. Routine monitoring of renal function is recommended during treatment.
LiverSAFE IF PRESCRIBED
Carbokem Novo 150mg Injection appears to pose minimal risk for individuals with hepatic impairment. Current evidence indicates dose modification may be unnecessary in this population. Physician consultation is advised.
What if you forget to take Carbokem Novo 150mg Injection :
Should you forget a scheduled Carbokem Novo 150mg Injection, seek medical advice.
Facts to Know About Carbokem Novo 150mg Injection
| Label | Value |
|---|---|
| Pharmaceutical Category | Platinum-based compounds |
| Addictive | None. |
| Treatment Category | Cancer therapies |
| Mechanism of Action | Platinum-based anti-neoplastic agents |
3,018 People bought this recently